The accumulation of macrophages in some tissues can induce inflammatory reactions in obesity. Gpr97 is highly expressed in some immunocytes, but its potential role in inflammatory regulation has not been revealed clearly. In our research, we investigated Gpr97 in regulating macrophage inflammation and metabolic dysfunction in the high-fat diet (HFD)-induced obese mice. The major metabolic phenotyping were not different after Gpr97 knockout in HFD-fed mice. Similar pathological alterations in adipose tissue, liver, and kidney were observed in Gpr97 −/− HFD mice compared with WT-HFD mice. In white adipose tissue, loss of Gpr97 reduced the ratio of M1-macrophages and increased the M2-macrophage ratio, which was opposite to that seen in the wild-type HFD mice. More macrophages invaded in the liver and kidney after Gpr97 knockout in HFD mice. Furthermore, the levels of TNF-α were higher in the liver and kidney of Gpr97 −/− HFD mice compared to those in wild-type HFD mice. The data indicate that Gpr97 might be required for local inflammation development in obesity-relative tissues, but does not play a role in metabolic disorder in HFD-induced obesity.
receptors (GPCRs) have been identified as important regulators in obese metabolic disorder, such as GPR119 and GPR120 15, 16 . GPR97, as well as GPR56 and GPR114, is a member of the adhesion GPCR family, whose encoding genes are all on the long arm of chromosome 16 17 . In mice, Gpr97 is only expressed in the hypothalamus, heart, kidney, and especially highly on thymus, spleen and blood 18 . In immune cells, GPR97 is expressed on leukocytes, such as neutrophils, eosinophils, and mast cells 17 . Recently, it was reported that the GPR97 plays a role in regulating B-cell fate 19 and migration of lymphatic endothelial cells 20 . It was also reported that the expression of GPR97 was significantly down-regulated when using colony-stimulating factor-1 (CSF-1/M-CSF) or granulocyte macrophage colony-stimulating factor (GM-CSF) to stimulate primary human macrophages differentiation from monocytes 21 , but its molecular mechanism in macrophage polarization and the related inflammatory response have not yet been reported. It seems that GPR97 might play an important role in immune system, but whether it also functions in inflammation during obesity has yet to be determined. Here we used Gpr97-knockout mice to elucidate whether Gpr97 has a role in macrophage-related inflammation and obesity-induced metabolic syndrome.
Results
Gpr97 is not involved in obesity and fasting blood glucose in HFD mice. The mice were fed with 60% calories in fat for 16 weeks to induce the metabolic syndrome. Metabolic phenotype, including food intake, body weight and glucose tolerance, was examined in mice. The quantity of food intake and body weight was recorded once a month. According to the collected data, there was no obvious difference in food intake between WT and Gpr97 −/− HFD-fed mice (Fig. 1a ). Although HFD-fed mice were significantly heavier than chow-fed mice, especially after 12-weeks (P < 0.05), no alteration was shown in Gpr97-deficient HFD-fed mice (Fig. 1b ). Moreover, we used an intraperitoneal glucose tolerance test (ipGTT) to examine glucose tolerance in our mice model. The fasting blood glucose of HFD mice was much higher than that of the chow-fed mice from 15 min (P < 0.01), but there was no change after loss of Gpr97 in HFD mice compared with WT HFD mice ( Fig. 1c ). These data indicate that Gpr97 deficiency does not influence the body weight or glucose tolerance of HFD mice.
Gpr97 does not play a role in HFD-induced metabolic syndrome. To determine whether Gpr97
impacts on HFD-induced metabolic syndrome, the levels of some metabolites in serum were measured in mice. The levels of cholesterol, glucose, high-density cholesterol lipoprotein (HDL), and low-density cholesterol lipoprotein (LDL) in serum were increased in both HFD-fed WT and Gpr97 −/− mice. However, there was no significant alteration of these serum parameters after Gpr97 deficiency in HFD-fed mice ( Fig. 2a-d ). The levels of albumin, carbamide, creatinine, triglyceride, and uric acid in serum were measured in mice. However, the HFD did not induce these indicators altering even in Gpr97 −/− HFD mice ( Fig. 2e -i). According to the metabolite analysis, Gpr97 is not involved in metabolic syndrome during HFD-induced obesity in mice.
Gpr97 is involved in the M1/M2 polarization of macrophages in white adipose tissue. White adipose tissue (WAT), which is a critical regulator of adiposity and energy metabolism, has been found to undergo metabolic changes during a high-fat diet 22 . Adipocyte hypertrophy and hyperplasia occurs in HFD-induced obesity, including overgrowth of WAT 23 . In our results, hypertrophy of WAT was a typical change in HFD mice, but the morphology of WAT did not significantly alter between WT and Gpr97 −/− HFD mice ( Fig. 3a ). It has been reported that the HFD will result in the accumulation of macrophage in WAT, which can lead to inflammation 24 . According to the alteration in the mRNA level of the macrophage marker F4/80, we found that Gpr97 deficiency can cause a reduction in macrophage invasion of WAT in HFD-fed mice (Fig. 3b ). The general view of the inflammatory reactions in WAT is an imbalance in the ratio of M1/M2 macrophages 24 . We analyzed the relative mRNA expression of cytokines associated with M1-and M2-polarized macrophages to confirm the function of Gpr97 in M1/M2 polarization of WAT macrophages. The M1-polarized-related parameters TNF-α , IL-6, IL-1β and CD86 displayed a decrease in Gpr97 −/− HFD mice compared to WT HFD mice ( Fig. 3c-f ). Meanwhile, the M2-polarized-related parameters, including CD68, CD163, CD206, Arg1 and IL-10 were increased in Gpr97 −/− HFD mice ( Fig. 3g -k). The accumulation of M1 "pro-inflammatory" macrophages and the reduction of M2 "anti-inflammatory" macrophages in white adipose tissue can lead to adipose tissue dysfunction 24 . We found that Gpr97 deficiency can reverse this imbalance of M1/M2 macrophages in WAT. In Gpr97 −/− HFD mice, M2 macrophages were increased and M1 macrophages were decreased obviously, which indicate that Gpr97 might contribute to the local inflammatory reactions charged of M1-macrophages. In the obesity induced by HFD, loss of Gpr97 will cause opposite imbalance of M1/M2 and reduce levels of inflammatory cytokines in WAT of mice.
Gpr97 enhances hepatic inflammation in HFD mice. The liver plays an important role in lipid metabolism, and hepatic steatosis was measured in an obese animal model 8 . HFD not only introduced obesity, but was also involved in glycometabolism and lipid metabolism in the liver. In our HFD mice, we used the Oil Red O stain to visualize hepatic neutral lipid accumulation in liver sections. The accumulation of lipid was severe in the livers of mice fed the HFD, but this accumulation was not significantly different between WT and Gpr97 −/− HFD mice ( Fig. 4a ). Next, we measured the metabolism of carbohydrate in the liver by periodic acid-Schiff (PAS) staining, and found that there was more glycogen storage in the liver in HFD-fed mice. However, there was no difference between WT and Gpr97 −/− mice (Fig. 4b ). The loss of Gpr97, therefore, did not affect lipid or glycogen storage, or metabolic disorder, in the HFD-induced liver.
To determine the function of Gpr97 in the liver of HFD mice, we measured the mRNA expression of metabolic factors, including those involved in transcriptional regulators which influence pathways of fatty acid oxidation (FoxO1, Pparα , Pgc1α , Pgc1β , Errα , Prc and Atp5s) ( Fig. 5a ), mitochondrially encoded genes (ND1, ND2, ND4, ATP6, ATP8 and COX2) ( Fig. 5b ), fatty acid oxidation (Acox1, Fgf21), mitochondrial function (Cs, Atp5g1), lipogenesis (SREBP2, Fasn), glucose metabolism (PEPCK, G6Pase) ( Fig. 5c ), and inflammation (F4/80, CD68, TNF-α , IL-6 and IL-1β ) ( Fig. 5d) 25 . These genes, which are involved in the major metabolic pathways and inflammatory reactions in the liver, showed slightly higher expression in Gpr97 −/− mice than in WT mice under a HFD-fed. Gpr97 deficiency, therefore, will aggravate some key gene expression which are involved in hepatic metabolism such as transcriptional regulation in fatty acid oxidation and mitochondrial function. Moreover, the inflammatory factor TNF-α , IL-6 and IL-1β were increased after Gpr97 knockout in HFD-fed mice. The higher expression of F4/80 and CD68 indicates that more macrophages gathered in the liver of Gpr97 −/− HFD mice, and that the loss of Gpr97 may cause more serious inflammation and metabolic stress in the liver of obese mice.
Effect of Gpr97 on HFD-induced renal inflammation. HFD can also cause renal inflammation and hypofunction 26 . Renal structural changes were evaluated by histochemistry with the PAS stain after HFD. Clear and unbroken structures of renal sections were shown in both WT and Gpr97 −/− chow-fed mice. There was also no interstitial fibrosis in the renal tubules or glomeruli. Mice fed the HFD exhibited renal injury, such as renal tubular epithelial cell cytoplasm vacuole degeneration, mesangial matrix expansion, and increased renal interstitial cells (Fig. 6a ). However, the absence of Gpr97 did not impact upon the HFD-induced renal injury. In HFD-fed mice, a high inflammation status would increase renal injury and lipid metabolic disorder, and some inflammatory markers, such as TNF-α , IL-6, and MCP-1, were induced by the HFD 27, 28 . Next, we measured the alterations in renal inflammatory cytokines in HFD mice after Gpr97 knockout. In Gpr97-deficient HFD mice, there were more macrophages invading the kidney according to the increase in F4/80 mRNA levels ( Fig. 6b) . Meanwhile, the inflammatory factor TNF-α was increased in Gpr97 −/− HFD mice compared with that in WT HFD mice ( Fig. 6c ), but there was no significant change in IL-1β and CD86 after Gpr97 knockout in HFD mice ( Fig. 6d,e ). So Gpr97 did not affect ratio of M1-polarized macrophages in kidney of HFD-fed mice. Further, we detected markers of M2-polarized macrophages including CD68, CD163, CD206, Arg1 and IL-10 in kidney and found increasing of those in kidney after Gpr97 deficiency in HFD-mice ( Fig. 6f-j ). According to our results, Gpr97 might be involved in the renal macrophage-inflammatory reaction and macrophage invasion in HFD mice, but not in the imbalance in the ratio of M1/M2 macrophages.
Discussion
Obesity is a chronic low-grade inflammatory disease 29 . Inflammation plays an important role in the pathological process of obesity. For obese rodents and humans, activated macrophages infiltrate metabolic tissues, including adipose tissue 10, 12 , liver 30, 31 , and kidney 32 , and such a large number of macrophages can cause serious local inflammation. Furthermore, they can impair the balance of the resident macrophage population and can affect the metabolic regulation function in these tissues 9, 33 . However, how specific genes involved in the regulation of tissue-specific inflammation and metabolic function are induced by a HFD has rarely been reported. A family of GPCRs were found that have important roles in various physiological and pathological processes, such as inflammatory regulation 34, 35 . The potential functions of Gpr97, which is an adhesion GPCR, are little known. Gpr97 has shown effects on B-lymphocyte development 19 and migration of lymphatic endothelial cells 20 . Here we focused on the role of Gpr97 on tissue-specific inflammation in HFD-induced obese mice.
Firstly, we determined whether Gpr97 had a function in HFD-induced metabolic abnormalities. The general physiological parameters, the intraperitoneal glucose tolerance, and metabolic characterization were examined in both WT and Gpr97 −/− mice fed a chow diet or the HFD. Our results showed that the Gpr97 −/− mice had almost equal levels of physiological parameters and serum parameters after the HFD. In the ipGTT test, there was also no significant difference between the wild-type and Gpr97-knockout obese mice (Figs 1 and 2) . Therefore, Gpr97 might not protect from or sensitize to the development of HFD-induced obesity, glucose tolerance, and systemic metabolic regulation in mice. Next, we focused on the function of Gpr97 in some important tissues involved in HFD-induced obesity.
WAT is regarded as an active metabolic tissue that can produce adipokines, as well as pro-or anti-inflammatory cytokines capable of regulating carbohydrate, lipid metabolism and local inflammation 36 . To respond to excess nutrients, WAT showed hypertrophy and hyperplasia in HFD-fed mice (Fig. 3a) . It was reported that adipocyte size is related to insulin sensitivity and human with smaller adipocytes have a lower degree of inflammation 37 . Moreover, obesity can also induce macrophage invasion into WAT and can lead to WAT inflammation. The accumulated macrophages in WAT secrete pro-inflammatory factors to enhance metabolic dysfunctions 38 . Our results indicate that Gpr97 deficiency reduces macrophage invasion into WAT (Fig. 3b ). The balance in the ratio of the macrophage population in WAT plays a key role in the development of HFD-induced obesity. In lean rodents, there are more M2-macrophges in adipose tissue, which are known to secrete anti-inflammatory cytokines 39 . In contrast, in obese animals, more activated macrophage and monocytes were recruited to the WAT, which turn into M1-macrophages. During this process, pro-inflammatory cytokines, including TNF-α and IL-1β , produced by M1-macrophages are capable of limiting glucose uptake in peripheral tissue 36, 40, 41 . Interestingly, we found that less macrophages invasion in the WAT and there was a reversed imbalance of ratio of M1/M2 macrophages in the WAT of obese Gpr97-knockout HFD-fed mice. This indicates that loss of Gpr97 will cause an M2-macrophage-related anti-inflammatory response to modulate healing repair process in WAT. Such evidence suggests that Gpr97 could modulate macrophage polarization during metabolic disorder and local inflammation in adipose tissue. However, further studies should be carried out to determine the potential mechanisms for macrophage polarization and the inflammatory reaction regulated by Gpr97 in the HFD-induced WAT.
Furthermore, for metabolic organs, the liver has a central position in the endocrine and metabolic system. For example, it plays a vital role in the metabolism of sugar, sugar storage and decomposition, and regulation of blood glucose. Excessive lipogenesis contributes to the development of hyperglycemia and hepatic steatosis 9, 42 . Lipid and glycogen accumulation occurred after 16 weeks of the HFD in both WT and Gpr97-knockout mice. Similar to previous results in white adipose tissue, Gpr97 may not be important enough to affect the hepatic phenotypic alterations seen during HFD-induced obesity. However, Gpr97 deficiency led to a slight increase in the expression of major metabolic genes involved in different physiological process of the liver. It was known that HFD causes hepatic lipid accumulation and that the complex and coordinated metabolic processes are also aggravated, including lipogenesis, fatty acid oxidation, glucose metabolism, mitochondrial function and metabolic transcriptional regulation in the liver 25, [43] [44] [45] [46] . According to our results, loss of Gpr97 might slightly increase these metabolic programs in mRNA levels. Meanwhile, inflammatory cytokines including TNF-α , IL-6 and IL-1β and number of macrophages were increased sharply in the liver after Gpr97 knockout in HFD mice. In summary, Gpr97 may participate in the regulation of expression of metabolic factors and the macrophage-related inflammatory response in liver, and the loss of Gpr97 may cause more serious hepatic dysfunction and inflammation. But how Gpr97 regulates altering of these factors in HFD-induced obesity should be further investigated.
Moreover, obesity is a potential risk factor for kidney disease in which fibrosis and inflammation play important roles. In HFD-fed mice, renal interstitial fibrosis and inflammatory cells were increased, which may develop into diabetes even diabetic nephropathy 26 . Whether Gpr97 contributes to the process is being considered. Our results indicate that Gpr97 did not affect the structural changes seen in the kidney during a HFD in mice (Fig. 6a ). However, Gpr97 seems to play an underlying role in the regulation of macrophage infiltration in HFD-induced renal inflammation. It was reported that macrophages can also be activated by a HFD and can infiltrated into the kidney 47 . After the loss of Gpr97, more macrophages invaded into the kidney, and the pro-inflammatory factor TNF-α was slightly increased in HFD-fed mice. Then we detected the altering of ratio of M1 and M2-related macrophages in kidney. It was found that more number of M2 macrophages and no change of ratio of M1 macrophages in kidney after Gpr97 knockout in HFD-fed mice. Therefore, we propose that Gpr97 is also involved in macrophage-related inflammation but not involved in macrophage polarization in kidney. How Gpr97 affects renal macrophage-related inflammatory response should be investigated further to reveal the potential regulatory mechanisms of Gpr97 in HFD-induced obesity.
In summary, we report the potential role of Gpr97 in metabolic syndrome and inflammation in HFD-fed mice. No phenotypic change was observed between wild-type and Gpr97 −/− HFD-fed mice, which indicates that Gpr97 does not play a role in the phenotypic development and metabolic homeostasis under such extreme conditions. However, further studies demonstrated that the absence of Gpr97 could recruit more macrophages into metabolic organs, including the liver and kidney. Then it would lead to initiation of tissue-specific macrophage-inflammation and promotion of metabolic regulation. Further, there was consistent evidence to suggest that Gpr97 was involved in macrophage polarization in WAT in HFD-induced obesity in mice. However, more evidence should be found to explain the mechanism of inflammation regulated by Gpr97 in the process of obesity induced by HFD.
Methods

Animals and diet. Six-week-old male C57BL/6 mice (Shanghai Laboratory Animal Company, China)
and Gpr97 −/− C57BL/6 mice were housed in the Laboratory Animal Center of East China Normal University. Gpr97 −/− mice were donated by the Dr. Zhugang Wang Laboratory (Shanghai Research Center for Model Organisms, Shanghai, China). Mice were raised in a regulated temperature (22 ± 2 °C) with a 12-h light/12-h dark cycle, and free access to food and water. Animals were fed a standard chow diet or a high-fat diet for 16 weeks. The blood glucose concentration, body weight, food intake, and water intake were measured once a week to monitor the general changes during the whole feeding process. Before experiments, the overnight fasted mice were sacrificed by dislocation of the vertebrae to obtain tissues and blood samples. Liver and kidney tissues were weighed and kept at − 80 °C for subsequent analysis. All animal experiments conformed to the regulations drafted by the Association for Assessment and Accreditation of Laboratory Animal Care in Shanghai and were approved by the East China Normal University Center for Animal Research.
Intraperitoneal glucose tolerance test. At the end of the feeding phase, an intraperitoneal glucose tolerance test (ipGTT) was performed on mice that had been fasted for 12 hours. Mice were intraperitoneally injected with glucose (1 g/kg), and then blood glucose concentration from vein blood were measured at 0, 15, 30, 45, and 60 minutes using ACCU-CHEK Active (Roche, Switzerland).
Blood biochemical indicator detection. Mice were fed with the high-fat diet or chow diet for 16 weeks to detect blood biochemical indicators. Samples were collected from the 16-18 h fasted mice after sacrifice, and then serum was obtained by centrifuging at 3000 g for 10 min at 4 °C. The serum was used to determine the levels of some major biochemical indicators, such as triglyceride (TG), cholesterol (CHO), and the serum lipid profile. The test of blood metabolites was conducted by ADICON Clinical Laboratory, Inc. (Shanghai, China). Tissue staining. Tissues, including epididymal fat tissue, liver, and kidney, from all sacrificed mice were collected and fixed in 4% paraformaldehyde overnight. Samples were incubated in graded ethanol, followed by embedding in paraffin. Six-μm sections, which were obtained by using a slicer (Leica, Germany), were stained with periodic acid-Schiff (PAS) stain for pathological examination 48 . The slices were incubated in periodic acid alcohol before PAS staining, and then were washed with sulfurous acid, followed by nucleolus staining using hematoxylin and eosin and mounting in glycerol.
Alternatively, fixed tissues were dehydrated in gradient sucrose solution, frozen in optimal cutting temperature (OCT) compound (SAKURA Tissue-Tek, USA). Ten-μm sections were obtained with frozen section (Leica, Germany) at − 10 °C, and stained with Oil Red O (Sigma, USA) to observe the lipid accumulation.
RNA isolation and reverse transcription. Total RNA was isolated from murine liver, adipose tissues and kidney using TRIzol reagent (Invitrogen, USA) according to the manufacturer's instructions. cDNA was reverse transcribed from RNA using the PrimeScript RT Master Mix Kit (TaKaRa, Japan), which was used as the template for the following real-time PCR reaction.
Real-time PCR. Quantitative real-time PCR was performed on a Stratagene Mx3005P Real-time PCR System
(Agilent Technologies, USA), using SYBR Premix Ex Taq ™ (TaKaRa, Japan) and following the manufacturer's instructions. Transcript levels of the housekeeping gene β -actin in the each sample were used for normalization. The gene-specific primer sequences are listed in Table 1 . 
